Corient Private Wealth’s MiMedx Group MDXG Stock Holding History

Corient Private Wealth’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.2K	Sell	21,094 -549	-3%	-$2K	﹤0.01%	2960
2026 Q1	$85.5K	Sell	21,643 -1,686	-7%	-$8.49K	﹤0.01%	2713
2025 Q4	$158K	Sell	23,329 -13,715	-37%	-$96.1K	﹤0.01%	2467
2025 Q3	$259K	Sell	37,044 -37,956	-51%	-$264K	﹤0.01%	2210
2025 Q2	$458K	Buy	75,000 +37,500	+100%	+$249K	﹤0.01%	1749
2025 Q1	$285K	Hold	37,500	–	–	﹤0.01%	1883
2024 Q4	$361K	Hold	37,500	–	–	﹤0.01%	1798
2024 Q3	$222K	Buy	37,500 +5,420	+17%	+$35.9K	﹤0.01%	2178
2024 Q2	$222K	Hold	32,080	–	–	﹤0.01%	2075
2024 Q1	$247K	Buy	32,080 +2,080	+7%	+$16.7K	﹤0.01%	1994
2023 Q4	$263K	Hold	30,000	–	–	﹤0.01%	1931
2023 Q3	$219K	Hold	30,000	–	–	﹤0.01%	1879
2023 Q2	$198K	Sell	30,000 -37,481	-56%	-$191K	﹤0.01%	1880
2023 Q1	$230K	Buy	+67,481	New	+$261K	﹤0.01%	1733

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Corient Private Wealth's MDXG Position: Q2 2026 in Review

Corient Private Wealth reduced its MiMedx Group (MDXG) stake by 2.5% in Q2 2026, selling an estimated $2K and leaving 21,094 shares worth $81.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

Corient Private Wealth first reported a position in MDXG in Q1 2023 and has held it in 14 quarters since. The position peaked at $458K in Q2 2025. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Corient Private Wealth held 21,094 shares of MiMedx Group worth $81.2K as of Q2 2026.
Corient Private Wealth sold 549 MiMedx Group shares in Q2 2026, an estimated $2K.
MiMedx Group made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2960 holding.
Corient Private Wealth first reported a position in MiMedx Group in Q1 2023 and has held it in 14 quarters since.
Corient Private Wealth's MiMedx Group position peaked at $458K in Q2 2025.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.